Clinical Trial Update: Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating darbepoetin alfa strategies to avoid transfusions in non-dialysis chronic kidney disease-related anemia; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia in Chronic Kidney Disease Patients Not On Dialysis

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anemia in Chronic Kidney Disease Patients Not on Dialysis | Phase 3 | Status: COMPLETED | Results posted: 2018-11-08